[HTML][HTML] Saracatinib, a Src tyrosine kinase inhibitor, as a disease modifier in the rat DFP model: sex differences, Neurobehavior, gliosis, neurodegeneration, and nitro …
M Gage, M Putra, L Wachter, K Dishman, M Gard… - Antioxidants, 2021 - mdpi.com
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro …
M Gage, M Putra, L Wachter, K Dishman, M Gard… - …, 2022 - search.proquest.com
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro …
M Gage, M Putra, L Wachter, K Dishman… - Antioxidants (Basel …, 2021 - europepmc.org
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
[PDF][PDF] a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis
M Gage, M Putra, L Wachter, K Dishman… - … , and Nitro-Oxidative … - pdfs.semanticscholar.org
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro …
M Gage, M Putra, L Wachter, K Dishman, M Gard… - Antioxidants, 2021 - agris.fao.org
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro …
M Gage, M Putra, L Wachter… - Antioxidants (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
[HTML][HTML] Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and …
M Gage, M Putra, L Wachter, K Dishman, M Gard… - …, 2022 - ncbi.nlm.nih.gov
Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …
causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective …